Apeloa Pharmaceutical Co Ltd (000739) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.070x

Based on the latest financial reports, Apeloa Pharmaceutical Co Ltd (000739) has a cash flow conversion efficiency ratio of 0.070x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥446.18 Million ≈ $65.29 Million USD) by net assets (CN¥6.35 Billion ≈ $928.67 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Apeloa Pharmaceutical Co Ltd balance sheet independence to measure how much of total assets are equity-financed.

Apeloa Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (1998–2025)

This chart illustrates how Apeloa Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 000739 cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

Apeloa Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Apeloa Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
XTC New Energy Materials Xiamen Co Ltd SHG:688778	0.025x
China Railway Construction Heavy Industry Corp Ltd SHG:688425	0.024x
KPJ Healthcare Bhd KLSE:5878	0.124x
Grupa KĘTY SA WAR:KTY	0.134x
Zhende Medical Co Ltd SHG:603301	0.017x
Addsino Co Ltd SHE:000547	0.047x
First Hawaiian Inc NASDAQ:FHB	0.058x
Stride Inc NYSE:LRN	0.135x

Annual Cash Flow Conversion Efficiency for Apeloa Pharmaceutical Co Ltd (1998–2025)

The table below shows the annual cash flow conversion efficiency of Apeloa Pharmaceutical Co Ltd from 1998 to 2025. For the full company profile with market capitalisation and key ratios, see Apeloa Pharmaceutical Co Ltd stock valuation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥6.35 Billion ≈ $928.67 Million	CN¥1.23 Billion ≈ $180.09 Million	0.194x	+8.29%
2024-12-31	CN¥6.75 Billion ≈ $987.72 Million	CN¥1.21 Billion ≈ $176.88 Million	0.179x	+8.18%
2023-12-31	CN¥6.23 Billion ≈ $911.71 Million	CN¥1.03 Billion ≈ $150.92 Million	0.166x	-31.10%
2022-12-31	CN¥5.52 Billion ≈ $807.64 Million	CN¥1.33 Billion ≈ $194.05 Million	0.240x	+98.74%
2021-12-31	CN¥5.06 Billion ≈ $740.44 Million	CN¥611.75 Million ≈ $89.52 Million	0.121x	-49.90%
2020-12-31	CN¥4.39 Billion ≈ $642.49 Million	CN¥1.06 Billion ≈ $155.04 Million	0.241x	-33.15%
2019-12-31	CN¥3.77 Billion ≈ $551.37 Million	CN¥1.36 Billion ≈ $199.02 Million	0.361x	+45.01%
2018-12-31	CN¥3.35 Billion ≈ $489.52 Million	CN¥832.69 Million ≈ $121.85 Million	0.249x	+261.87%
2017-12-31	CN¥3.05 Billion ≈ $446.31 Million	CN¥209.80 Million ≈ $30.70 Million	0.069x	-0.24%
2016-12-31	CN¥2.62 Billion ≈ $382.88 Million	CN¥180.42 Million ≈ $26.40 Million	0.069x	-62.22%
2015-12-31	CN¥2.42 Billion ≈ $353.65 Million	CN¥441.16 Million ≈ $64.56 Million	0.183x	-46.49%
2014-12-31	CN¥2.31 Billion ≈ $337.43 Million	CN¥786.64 Million ≈ $115.11 Million	0.341x	+232.78%
2013-12-31	CN¥1.86 Billion ≈ $271.86 Million	CN¥190.45 Million ≈ $27.87 Million	0.103x	-58.33%
2012-12-31	CN¥1.37 Billion ≈ $199.83 Million	CN¥335.90 Million ≈ $49.15 Million	0.246x	-25.14%
2011-12-31	CN¥1.23 Billion ≈ $180.21 Million	CN¥404.62 Million ≈ $59.21 Million	0.329x	+119.48%
2010-12-31	CN¥808.57 Million ≈ $118.32 Million	CN¥121.05 Million ≈ $17.71 Million	0.150x	-42.88%
2009-12-31	CN¥794.78 Million ≈ $116.30 Million	CN¥208.30 Million ≈ $30.48 Million	0.262x	+112.87%
2008-12-31	CN¥768.11 Million ≈ $112.40 Million	CN¥94.57 Million ≈ $13.84 Million	0.123x	-46.98%
2007-12-31	CN¥750.11 Million ≈ $109.76 Million	CN¥174.20 Million ≈ $25.49 Million	0.232x	-36.48%
2006-12-31	CN¥436.05 Million ≈ $63.81 Million	CN¥159.43 Million ≈ $23.33 Million	0.366x	+72.33%
2005-12-31	CN¥411.93 Million ≈ $60.28 Million	CN¥87.40 Million ≈ $12.79 Million	0.212x	+65.59%
2004-12-31	CN¥371.08 Million ≈ $54.30 Million	CN¥47.54 Million ≈ $6.96 Million	0.128x	-60.01%
2003-12-31	CN¥328.83 Million ≈ $48.12 Million	CN¥105.36 Million ≈ $15.42 Million	0.320x	+3243.46%
2002-12-31	CN¥293.69 Million ≈ $42.98 Million	CN¥2.81 Million ≈ $411.85K	0.010x	+536.80%
2001-12-31	CN¥259.70 Million ≈ $38.00 Million	CN¥-569.79K ≈ $-83.38K	-0.002x	-108.50%
2000-12-31	CN¥274.23 Million ≈ $40.13 Million	CN¥7.08 Million ≈ $1.04 Million	0.026x	+138.74%
1999-12-31	CN¥307.93 Million ≈ $45.06 Million	CN¥-20.52 Million ≈ $-3.00 Million	-0.067x	-150.12%
1998-12-31	CN¥226.31 Million ≈ $33.12 Million	CN¥30.10 Million ≈ $4.40 Million	0.133x	--

About Apeloa Pharmaceutical Co Ltd

SHE:000739 China Drug Manufacturers - Specialty & Generic

Market Cap

$3.41 Billion

CN¥23.30 Billion CNY

Market Cap Rank

#4496 Global

#700 in China

Share Price

CN¥20.11

Change (1 day)

-0.54%

52-Week Range

CN¥15.02 - CN¥21.00

All Time High

CN¥39.53